SLx-4090 Uses, Dosage, Side Effects and more
SLx-4090 is a microsomal triglyceride transfer protein (MTTP) inhibitor potentially for the treatment of type 2 diabetes.
| Attribute | Details |
|---|---|
| Trade Name | SLx-4090 |
| Generic | SLx-4090 |
| Type | |
| Formula | C31H25F3N2O4 |
| Weight | Average: 546.546 Monoisotopic: 546.176641782 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in hyperlipidemia.
How SLx-4090 works
SLx-4090 inhibits Microsomal Triglyceride Transfer Protein (MTP). It acts selectively in the enterocytes lining the gastrointestinal tract, preventing the formation of chylomicrons which are used to transport triglyceride (TG) and cholesterol into the systemic circulation.
